Open company graph database — free web & API
Login

CM Plus Singapore Pte. Ltd.

シーエムプラスシンガポール株式会社Alias
Ticker
—
Listed market
—
Country
Singapore
Employees (non-consolidated)
—
Related companies
4
§01

Basic information

BASIC
Head office
11 North Buona Vista Drive, #08-09 (Servcorp) The Metropolis Tower 2, Singapore 138589
Chief executive
Tsunehiro Togashi
Employees (non-consolidated)
Employees (consolidated)
Start date
2007-08-17
End date
§02

Websites

1 DOMAINS
§03

Business

29
One-Stop Service for Production FacilitiesConstruction Management by CM PlusProject Management Consultant (PMC)Facility ConstructionPharmaceuticals and Medical DevicesFoodCosmeticsHome Care ProductsSemiconductors and Electronic DevicesData CentersChemical PlantsLogisticsHalalConsultingPharmaceutical GMP & GDP ConsultingQMS for Medical DevicesRegulatory Affairs ConsultingValidation ConsultingRegenerative Medicine ConsultingContamination Control Strategy (CCS) ConsultingData Integrity (DI) ConsultingEducation/Training SupportTechnical Information ServicesCORRESSAEnergy Management Solutions “CMP Way”Engineering, Project ManagementAbout Construction ManagementInternational Project Management Supportpharmo.AI
§04

Related companies

4 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
CM Plus Co., Ltd.
Group Parent
Indonesia
Singapore
Vietnam
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

13 EVENTS

Established CM Plus Corporation.Sources

Provided engineering services supporting production facility projects.Sources

Started consulting services for the pharmaceutical industry.Sources

Expanded engineering services to the medical device and data center sectors.Sources

Launched the GMP platform for GMP information dissemination services.Sources

Established a subsidiary in Vietnam.Sources

Started GMP education services.Sources

Established a subsidiary in Singapore.Sources

Established a subsidiary in Indonesia.Sources

Relocated the Japanese headquarters to Minato Mirai Grand Central Tower.Sources

Established the Singapore Group Headquarters and transferred group holding functions.Sources

Held the 15th-anniversary celebrations.Sources

Expansion of target industries and service categoriesSources

§07

News

14 ARTICLES

CM Plus and Mescells Sign MOU for Regenerative Medicine CooperationSources

CM Plus Singapore Pte. Ltd. and Vietnam's Mescells (MSC) have signed a Memorandum of Understanding (MOU) aimed at cooperation in the field of regenerative medicine as part of the public-private partnership forum between Vietnam and Japan. The agreement focuses on advancing the standardization of cell manufacturing facilities (Cell Processing Center – CPC).

Part 2 of GMP WATCH NEWS Series PublishedSources

The latest Part 2 of the GMP WATCH NEWS series from CM Plus Singapore Pte. Ltd. has been published. The article discusses the latest global trends in GMP and regulatory compliance.

CM Plus Singapore to Speak at GMP/EU-GMP Workshop 2026Sources

CM Plus Singapore Pte. Ltd. will participate as a sponsor and presenter at the ISPE Singapore – VNPCA GMP Workshop 2026 in Ho Chi Minh City, Vietnam. The workshop is scheduled for November 5–6, 2026, and will focus on GMP practices in the pharmaceutical industry.

CM Plus Singapore to Exhibit at Regenerative Medicine JAPAN 2026Sources

CM Plus Singapore Pte. Ltd. will exhibit at Regenerative Medicine JAPAN 2026, held at PACIFICO Yokohama from October 7 to 9, 2026. Individual consultations will be available during the event. President Hiroto Katayama and Yasuyuki Suga will give presentations.

CM Plus Relaunches Overseas Factory SiteSources

On September 16, 2026, CM Plus fully renewed and relaunched its Overseas Factory Construction Information Platform, marking the first major overhaul since its launch in August 2020. The platform reorganizes accumulated research to help companies expand factories into Southeast Asia, making reliable on‑ground information easier to access. New column series by external experts with deep regional knowledge have also been introduced.

Microorganism Series – Part 4Sources

The updated “Microorganism and Sterilization Management [2026]” column series has reached Part 4, continuing its 50‑part legacy on the GMP Platform. Part 4 focuses on the fundamentals of microbiology, building on earlier installments that cover foundational concepts and practical gaps for professionals.

PMDA Orange Letter Series Expands to Part 2Sources

Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has released a new column series titled “PMDA Orange Letter,” now extending to Part 2. The series publishes anonymized, practical findings from GMP inspections to encourage voluntary quality improvements and proactive compliance at pharmaceutical manufacturing sites. Rather than merely listing violations, the articles focus on root causes and provide real‑world case studies based on the Japanese GMP Ministerial Order, covering all critical quality elements.

Seminar on Quality & ExcipientsSources

PT CMPlus Consulting Indonesia, in partnership with BADIKLAT Ikatan Apoteker Indonesia, hosted a webinar on June 30, 2026, to raise quality standards in the Central Java pharmaceutical sector. The session focused on navigating PIC/S GMP (CPOB) regulations and attracted mainly QA and QC specialists.

CM Plus & Memsift Deploy Circular WaterSources

CM Plus and Memsift Innovations have signed a strategic Memorandum of Understanding to accelerate the deployment of next‑generation circular water infrastructure solutions across Japan and Southeast Asia. The partnership combines CM Plus’s engineering and project‑management expertise with Memsift’s advanced membrane and thermodynamic separation technologies. Together, they aim to enhance water reuse and sustainability in advanced manufacturing across the region.

iVEXL Interview Featured by ILSources

An interview article on iVEXL was highlighted as a case study on IL Contract Packaging’s official website and LinkedIn. The feature showcases the interview and links to the full article. Links to the IL Group website (English and Japanese) and LinkedIn post are provided.

§09

Sources & updates

SOURCES
↑